首页>
外国专利>
Inhibitor of human myeloid leukemia on base of asymmetric cobalt trichloroacetate dimer
Inhibitor of human myeloid leukemia on base of asymmetric cobalt trichloroacetate dimer
展开▼
机译:基于不对称三氯乙酸钴二聚体的人骨髓白血病抑制剂
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention relates to the application of coordinative combinations in medicine, namely to the use of monohydrate (µ-aqua)-bis-(µ-trichloroacetato)-tri(aqua)cobalt-aqua-bis-(trichloroacetato)cobalt as inhibitor of human myeloid leukemia.Summary of the invention consists in that as inhibitor of human myeloid leukemia is claimed (µ-aqua)-bis-(µ-trichloroacetato)-tri(aqua)cobalt-aqua-bis-(trichloroacetato)cobalt monohydrate of the formula:The result of the invention consists in the establishment at the known (µ-aqua)-bis-(µ-trichloroacetato)-tri(aqua)cobalt-aqua-bis-(trichloro-acetato)cobalt monohydrate of the anticancer activity, exceeding 1,25…1,35 times the analogous characteristics of the dimeric trihydrate of aquaethylene-diaminetetraacetatobismuthate (III) of 1,6-dimitrotetraaminecobalt (III) and dehydrate of ethylenediaminetetraacetatobismuthate (III) of oxalatotetraaminecobalt (III) (of the analogue).
展开▼